Work

Pharmacokinetic and biomarker analysis in a phase II trial of the HDAC inhibitor romidepsin, FK228

Year: 2008

Type: article

Source: Cancer Research

Authors: Richard Piekarz, Erin R. Gardner, Zhirong Zhan, Victoria Luchenko, Seth M. Steinberg, David J. Liewehr, Kenneth Steadman, Robin Frye, William D. Figg, Miles Prince, Steve Allen, Jasmine Zain, Mark Kirschbaum, Susan E. Bates

Institutions: City Of Hope National Medical Center, North Shore University Hospital, City of Hope, National Cancer Institute

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2919752764

FWCI: 0.124

Cites:

Cited by: 1

Related to: 20